Skip to main content
Premium Trial:

Request an Annual Quote

Definiens Places New Tissue Array Analysis Platform at Karmanos Cancer Institute

Premium

By Justin Petrone

Definiens this week announced that scientists at the Barbara Ann Karmanos Cancer Institute in Detroit will use its tissue microarray image analysis software in their cancer-diagnosis and biomarker-development projects.

The Karmanos Cancer Institute will use Definiens' Tissue Studio 2.0 digital pathology software to automate tissue section and microarray analysis. Researchers at the institute "aim to improve the speed and accuracy of diagnosis by automating image analysis of tissue sections stained for morphology and biomarker expression, as well as tissue microarrays measuring clinically relevant biomarkers," according to Munich-based Definiens.

Thomas Colarusso, vice president of Definiens' North American sales and operations, told BioArray News that the newly launched software provides "full tissue microarray support, for both bright field and immunofluorescent images, and supports metadata import on a per-core basis."

He said that Definiens' software can be used to "look for correlations between biomarker expression, tumor morphology, and clinical endpoints of interest."

Gerold Bepler, president and CEO of the Karmanos Institute, said in a statement that the institute will use Tissue Studio to analyze cancers, including lung, breast, and pancreatic cancer, on the cellular and sub-cellular level.

"Automating image analysis in our research will significantly enhance our ability to apply knowledge of cancer characteristics to patient diagnosis and treatment," Bepler said. "The software will help us classify tumors and generate better prognostic and predictive data. We expect this will improve our ability to stratify patients for the most promising clinical approach."

Financial terms of the deal were not discussed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.